$IMMB "MUST READ" Alright $IMMB Investors and Future

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

[b]$IMMB[/b] >>>

[b]"MUST READ" [/b]Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an [b]ABSOLUTE LIFE CHANGER[/b].

[b]Amazing Website[/b] >> http://www.immunotechlab.com/

[b]As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. [i]More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB[/i]! [/b]

[b]Why is that important to IMMB[/b], there is simply room for Competitors and [b]definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday. [/b]

[b]Well here is my take as to WHY you should BUY IMMB[/b]....

[b]IMMB currently carries a HV/AIDS PATENT valued at over $5 Million [/b]>> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent...IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents....Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so [b]on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors. [/b]

[b]Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell! [/b]

[b]As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.[/b]

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

[b]Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided[/b] >> http://www.otcmarkets.com/stock/IMMB/news

[b]Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients [/b]

[b]Followed by a much BIGGER News RELEASE JAN/2013 [/b]Link Provided >> http://www.otcmarkets.com/stock/IMMB/news

[b]Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines[/b]

[b]Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided [/b]>> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures (link)http://ih.advfn.com/p.php?pid=nmona&article=56128728

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, [b]We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE... [/b]

From the last PR and in the words of MR.BO LINTON (read BOLD)>>

Mr. Linton further commented the company recently [b]received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug[/b]". [i]If confirmed the initial order would be in excess of several Million Dollars.[/i][b] This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company. In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone. [/b]

[b]Now that you are seeing what I am seeing I will show you the KICKER >>

[/b]

[b]CURRENT SHARE STRUCTURE[/b]

OUTSTANDING SHARES 60,500,000 give or take a handful

[b]FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON [/b](link provided) >> http://www.otcmarkets.com/stock/IMMB/news

Want More, I have more >>

[b]INSIDERS HOLDINGS 98% of O/S Here is the PROOF[/b] >>

Name of Shareholder Number of Shares

Harry Zhabilov 24,895,646 41.11

Ara Ghanime 24,895,646 41.11

Dow Jones Link 2,773,500 4.58

Allie Chang 600,000 1.0

Paul Felizian 600,000 1.0

Lord George Equities 5,400,000 9.0

Joseph Pittera 250,000 0.41

Harout Tovmasyan 151,000 0.25

Elie Sakayan 50,000 0.08

Hagop Parseghian 600,000 1.0

Others 339,896 0.46

So there you have it!

[b]PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM!

[/b]

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 2

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 6

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 2

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 5

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading

Top 5 Most Recently Viewed Articles

UBS Enhances Azelis Rating to 'Buy' on Strong Recovery Outlook

Updated Category News Views 192

UBS Upgrades Azelis to 'Buy' Based on Positive Market Signals In a significant move for investors, UBS Global Research has upgraded Azelis Group (EBR: AZE) from a "neutral" stance to a "buy" rating. This transition comes as analysts recognize the recovery potential and favorable valuation of the Belgium-based company. Positive Market Response Following the announcement...

Continue Reading
Algae-C Inc. Merges with Rockcliffe Labs for Enhanced Biotech Growth

Updated Category News Views 192

Algae-C Inc. Merges with Rockcliffe Labs for Enhanced Biotech Growth Algae-C Inc. is now officially part of Rockcliffe Labs, a Canadian late-stage biotech innovation platform. This strategic acquisition allows Algae-C to enhance its operational capabilities and leverage Rockcliffe Labs' extensive resources and expertise in the biotechnology sector. Transaction Overview...

Continue Reading
Crown Crafts, Inc. to Discuss Q2 Fiscal 2026 Earnings Soon

Updated Category News Views 126

Crown Crafts, Inc. to Announce Q2 Fiscal 2026 Results Crown Crafts, Inc. (NASDAQ: CRWS) has made an important announcement regarding its upcoming financial results. The company plans to share its operational performance for the second quarter of fiscal year 2026 before market openings on a specified date in November 2025. This event underscores Crown Crafts’ commitment...

Continue Reading
AFGB Stock Hits 52-Week Low, Analyzing Market Trends

Updated Category News Views 256

AFGB Stock Experiences 52-Week Low Amid Market Trends American Financial Group (NYSE: AFG) has recently seen its stock, PR B (AFGB), hit a concerning 52-week low, reaching $22.7. This notable decline comes as investors contend with a fluctuating market environment that has created uncertainty among many stocks. At a market capitalization of $11.5 billion, the company's...

Continue Reading
KBR Secures $113 Million Air Force Contract for Innovation

Updated Category News Views 63

KBR Secures $113 Million Air Force Contract for Innovation KBR, Inc. (NYSE: KBR) has officially announced that it’s landed a five-year contract worth $113 million. This important contract focuses on aeronautical systems research for the Air Force Life Cycle Management Center Mobility Directorate. Purpose of the Contract Awarded under the Department of Defense...

Continue Reading